Observational studyAnnals of oncology : official journal of the European Society for Medical Oncology2022

Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third study.

F Nelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.